share_log

艾德生物:关于厦门艾德生物医药科技股份有限公司回购注销2023年限制性股票激励计划部分限制性股票相关事项的法律意见书

Amoy Diagnostics: Legal opinion on matters relating to the repurchase and cancellation of some restricted stocks in the 2023 Restricted Stock Incentive Plan of Xiamen Aide Biomedical Technology Co., Ltd.

Sensex a share ·  May 8
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more